Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antithrombotic Therapy After Left Atrial Appendage Occlusion: Double Antiplatelet Therapy vs Apixaban

NCT05632445 is registered in ClinicalTrials.gov with DR. XAVIER FREIXA as lead sponsor.

NCT NCT05632445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05632445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antithrombotic Therapy After Left Atrial Appendage Occlusion: Double Antiplatelet Therapy vs Apixaban
Lead sponsor
DR. XAVIER FREIXA
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2019
Completion date
October 30, 2022
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

left atrial appendage occlusion